# Unrelated Cord Blood Transplantation for EBV-associated Lymphoproliferative Disorders

> **NCT07381738** · PHASE2 · RECRUITING · sponsor: **Fudan University** · enrollment: 80 (estimated)

## Conditions studied

- Epstein-Barr Virus-associated Lymphoproliferative Diseases
- Chronic Active Epstein-Barr Virus Infection
- EBV Associated Lymphoma
- Umbilical Cord Blood Transplant

## Interventions

- **PROCEDURE:** Umbilical cord blood transplantation as treatment of Epstein-Barr virus-associated lymphoproliferative diseases

## Key facts

- **NCT ID:** NCT07381738
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-01-01
- **Primary completion:** 2028-12-31
- **Final completion:** 2028-12-31
- **Target enrollment:** 80 (ESTIMATED)
- **Last updated:** 2026-02-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07381738

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07381738, "Unrelated Cord Blood Transplantation for EBV-associated Lymphoproliferative Disorders". Retrieved via AI Analytics 2026-08-22 from https://api.ai-analytics.org/clinical/NCT07381738. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*